262 related articles for article (PubMed ID: 34022954)
1. Why do poxviruses still matter?
Yang Z; Gray M; Winter L
Cell Biosci; 2021 May; 11(1):96. PubMed ID: 34022954
[TBL] [Abstract][Full Text] [Related]
2. The uses of poxviruses as vectors.
Vanderplasschen A; Pastoret PP
Curr Gene Ther; 2003 Dec; 3(6):583-95. PubMed ID: 14683453
[TBL] [Abstract][Full Text] [Related]
3. Poxvirus-driven human diseases and emerging therapeutics.
Srinivasan Rajsri K; Rao M
Ther Adv Infect Dis; 2022; 9():20499361221136751. PubMed ID: 36406813
[No Abstract] [Full Text] [Related]
4. Suppression of Poxvirus Replication by Resveratrol.
Cao S; Realegeno S; Pant A; Satheshkumar PS; Yang Z
Front Microbiol; 2017; 8():2196. PubMed ID: 29204136
[TBL] [Abstract][Full Text] [Related]
5. Adventures with poxviruses of vertebrates.
Fenner F
FEMS Microbiol Rev; 2000 Apr; 24(2):123-33. PubMed ID: 10717311
[TBL] [Abstract][Full Text] [Related]
6. In a nutshell: structure and assembly of the vaccinia virion.
Condit RC; Moussatche N; Traktman P
Adv Virus Res; 2006; 66():31-124. PubMed ID: 16877059
[TBL] [Abstract][Full Text] [Related]
7. Cross-species transmission and host range genes in poxviruses.
Yang CH; Song AL; Qiu Y; Ge XY
Virol Sin; 2024 Apr; 39(2):177-193. PubMed ID: 38272237
[TBL] [Abstract][Full Text] [Related]
8. Poxviruses and the evolution of host range and virulence.
Haller SL; Peng C; McFadden G; Rothenburg S
Infect Genet Evol; 2014 Jan; 21():15-40. PubMed ID: 24161410
[TBL] [Abstract][Full Text] [Related]
9. Poxvirus tropism.
McFadden G
Nat Rev Microbiol; 2005 Mar; 3(3):201-13. PubMed ID: 15738948
[TBL] [Abstract][Full Text] [Related]
10. NK cells and poxvirus infection.
Burshtyn DN
Front Immunol; 2013; 4():7. PubMed ID: 23372568
[TBL] [Abstract][Full Text] [Related]
11. Innate immune recognition of poxviral vaccine vectors.
Lousberg EL; Diener KR; Brown MP; Hayball JD
Expert Rev Vaccines; 2011 Oct; 10(10):1435-49. PubMed ID: 21988308
[TBL] [Abstract][Full Text] [Related]
12. Targeted and armed oncolytic poxviruses for cancer: the lead example of JX-594.
Breitbach CJ; Thorne SH; Bell JC; Kirn DH
Curr Pharm Biotechnol; 2012 Jul; 13(9):1768-72. PubMed ID: 21740365
[TBL] [Abstract][Full Text] [Related]
13. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
Hwang C; Sanda MG
Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
[TBL] [Abstract][Full Text] [Related]
14. Vector-based genetically modified vaccines: Exploiting Jenner's legacy.
Ramezanpour B; Haan I; Osterhaus A; Claassen E
Vaccine; 2016 Dec; 34(50):6436-6448. PubMed ID: 28029542
[TBL] [Abstract][Full Text] [Related]
15. Poxvirus Safety Analysis in the Pregnant Mouse Model, Vaccinia, and Raccoonpox Viruses.
Roper RL
Methods Mol Biol; 2017; 1581():121-129. PubMed ID: 28374246
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic Poxviruses.
Chan WM; McFadden G
Annu Rev Virol; 2014 Sep; 1(1):119-141. PubMed ID: 25839047
[TBL] [Abstract][Full Text] [Related]
17. Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxviruses.
Sampath P; Thorne SH
Oncolytic Virother; 2014; 3():1-9. PubMed ID: 27512659
[TBL] [Abstract][Full Text] [Related]
18. Immune response to poxvirus infections in various animals.
Smith SA; Kotwal GJ
Crit Rev Microbiol; 2002; 28(3):149-85. PubMed ID: 12385498
[TBL] [Abstract][Full Text] [Related]
19. Smallpox: can we still learn from the journey to eradication?
Smith KA
Indian J Med Res; 2013 May; 137(5):895-9. PubMed ID: 23760373
[TBL] [Abstract][Full Text] [Related]
20. The evolutionary biology of poxviruses.
Hughes AL; Irausquin S; Friedman R
Infect Genet Evol; 2010 Jan; 10(1):50-9. PubMed ID: 19833230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
